Multiple places across China have noted that local makeshift hospitals constructed during the COVID-19 pandemic remain idle. These announcements come after plans to construct a makeshift hospital in Jiamusi, Northeast China’s Heilongjiang Province have provoked a storm on social media.
Local authorities in places such as Southwest China’s Chongqing, Xingtai in North China’s Hebei Province and Zigong in Southwest China’s Sichuan Province noted that their makeshift hospitals are no longer being used as medical institutions and are now being used for other purposes or just lying idle.
China s first home-grown mRNA COVID vaccine rolled out in Hebei globalsecurity.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalsecurity.org Daily Mail and Mail on Sunday newspapers.
After attending “online schools” for three years, students and teachers in China are finally meeting their beloved classmates as they move on-site in the upcoming spring semester, with nearly 300 million people expected to return to campuses nationwide.
As the first batch to be “tested” after China downgraded its COVID-19 management, authorities urged educational institutions to fully restore the normal operation of teaching activities while ensuring the health and safety of students and teachers.
The US pharmaceutical giant Merck Sharp & Dohme (MSD) s China branch announced on Wednesday that, to meet the needs of Chinese patients and help China s fight against COVID-19, MSD launched licensing negotiations with Sinopharm to manufacture and supply molnupiravir in China.